Nonagen Bioscience announces CE mark for Oncuria® bladder cancer diagnostic ...Middle East

PR Newswire - News
Nonagen Bioscience announces CE mark for Oncuria® bladder cancer diagnostic
LOS ANGELES, June 16, 2022 /PRNewswire/— Nonagen Bioscience, a cancer diagnostics company, today announced CE marking for its Oncuria® immunoassay for bladder cancer. Nonagen Bioscience now has CE marking for its Oncuria® bladder cancer immunoassay, setting the stage for European sales....

Hence then, the article about nonagen bioscience announces ce mark for oncuria bladder cancer diagnostic was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Nonagen Bioscience announces CE mark for Oncuria® bladder cancer diagnostic )

Apple Storegoogle play

Last updated :

Also on site :



Latest News